Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |